| Authors: |
Saba L; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX., Haddad GC; Department of Hematology and Oncology, Myeloma and Amyloidosis Program, Cleveland Clinic Florida, Maroone Cancer Center, Weston., Greskovich J; Department of Radiation Oncology, BayCare Health, Tampa, St. Petersburg, FL., Sarna K; Department of Hematology and Oncology, Myeloma and Amyloidosis Program, Cleveland Clinic Florida, Maroone Cancer Center, Weston., Liang H; Department of Hematology and Oncology, Myeloma and Amyloidosis Program, Cleveland Clinic Florida, Maroone Cancer Center, Weston., Fu CL; Department of Hematology and Oncology, Myeloma and Amyloidosis Program, Cleveland Clinic Florida, Maroone Cancer Center, Weston., Chaulagain CP; Department of Hematology and Oncology, Myeloma and Amyloidosis Program, Cleveland Clinic Florida, Maroone Cancer Center, Weston. |
